IV Magnesium in the Treatment of Acute Dysmenorrhea
ConditionDysmenorrhea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorHavva Betül Bacak
About this trial
This prospective, randomized, double-blind clinical trial aims to evaluate the analgesic efficacy of intravenous magnesium sulfate in women presenting to the emergency department with acute dysmenorrhea. Participants will be randomized into two groups receiving either 2 ampoules of magnesium sulfate or intravenous dexketoprofen. Pain levels will be assessed using the Visual Analog Scale (VAS) before and after treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Magnesium Sulfate (2 Ampoules)
DrugIntravenous administration of 2 ampoules (8 ml total) of magnesium sulfate diluted in 100 ml normal saline, infused over 15 minutes.
Dexketoprofen
DrugIntravenous administration of 50 mg dexketoprofen diluted in 100 ml normal saline, infused over 15 minutes.
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Magnesium Sulfate 2 AmpoulesExperimental treatment 1 intervention
Group B: Intravenous DexketoprofenActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in pain intensity measured by Visual Analog Scale (VAS)
Pain severity will be assessed using the 0-10 Visual Analog Scale (VAS) before treatment and 1 hour post-treatment. The study will evaluate and compare the analgesic effect of two different doses of intravenous magnesium sulfate (2 ampoules vs. 3 ampoules) and compare both to intravenous dexketoprofen in women presenting with acute dysmenorrhea.
Time frame
Baseline and 1 hour after intravenous treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Havva Betül Bacak
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Sponsor institution
Source ClinicalTrials.gov